Lupus & Connective Tissue Diseases
From the Journals
Current Hydroxychloroquine Use in Lupus May Provide Protection Against Cardiovascular Events
Hydroxychloroquine demonstrated protective effects against cardiovascular events in patients with systemic lupus erythematosus.
Latest News
Monitor Asthma Patients on Biologics for Remission, Potential EGPA Symptoms During Steroid Tapering
Biologics have revolutionized the treatment of severe asthma, significantly improving patient outcomes.
From the Journals
GI Involvement Often Present at Time of Pediatric Lupus Diagnosis or Soon After
Gastrointestinal involvement should be considered in all pediatric patients with systemic lupus erythematosus, particularly if they have abdominal...
From the Journals
What’s Causing Raynaud Phenomenon Severity to Rise With High Temperatures?
Both extreme heat and cold were tied to more severe episodes of Raynaud phenomenon in a study of participants with systemic sclerosis.
Feature
Prediction, Management of Sjögren-Related Lymphomas Gain Ground With New Studies
Two European studies reported on a potentially strong predictive biomarker for marginal lymphoma in Sjögren disease and the effectiveness of...
From the Journals
Teclistamab Promising as a Treatment of Last Resort for Refractory Autoimmune Diseases
In small studies, teclistamab significantly improved autoimmune disease activity and demonstrated a good safety profile.
From the Journals
Systemic Sclerosis Without Scleroderma Has Unique Severity, Prognosis
Systemic sclerosis sine scleroderma may account for almost 10% of cases and shares clinical features with limited cutaneous systemic sclerosis.
From the Journals
Risk for Giant Cell Arteritis Rises With Air Pollution Levels
Exposure to high levels of particulate matter with diameter ≤ 10 μm was associated with an increased risk for giant cell arteritis but not...
Commentary
What Are the Best Supplements for Patients With Kidney Disease? A Few Stand Out
A dietitian provides advice on the best supplements for kidney disease, including fish oil, probiotics, and vitamin D.
From the Journals
Patients With Immune-Mediated Inflammatory Diseases, Type 2 Diabetes Reap GLP-1 Receptor Agonist Benefits, Too
GLP-1 RAs were associated with a decreased risk for all-cause mortality and major adverse cardiovascular events in patients with immune-mediated...
Conference Coverage
Fillers, Hyaluronidase Relieve Orofacial Changes in Patients with Scleroderma
The recommended treatment for scleroderma patients was to use nerve blocks for injecting HA filler or hyaluronidase and to minimize the injection...